ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer

Bibliographic Details
Title: ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer
Authors: Ying Mei, Qinglei Hang, Hongqi Teng, Fan Yao, Mei-Kuang Chen, Mien-Chie Hung, Yutong Sun, Li Ma
Source: Genes and Diseases, Vol 10, Iss 5, Pp 1739-1742 (2023)
Publisher Information: KeAi Communications Co., Ltd., 2023.
Publication Year: 2023
Collection: LCC:Medicine (General)
LCC:Genetics
Subject Terms: Medicine (General), R5-920, Genetics, QH426-470
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2352-3042
Relation: http://www.sciencedirect.com/science/article/pii/S2352304222002665; https://doaj.org/toc/2352-3042
DOI: 10.1016/j.gendis.2022.09.013
Access URL: https://doaj.org/article/97a5253843b54c42803d2b7c6e5b78b3
Accession Number: edsdoj.97a5253843b54c42803d2b7c6e5b78b3
Database: Directory of Open Access Journals
More Details
ISSN:23523042
DOI:10.1016/j.gendis.2022.09.013
Published in:Genes and Diseases
Language:English